Download as pdf or txt
Download as pdf or txt
You are on page 1of 25

The Nature of Drugs

& Drug Development


and Regulation
Karl C. Ablola, M.D.
Pharmacology and Toxicology
University of Santo Tomas
Topics
GENERAL PRINCIPLES

Pharmacology versus Toxicology


Nature of Drugs
Drug-Body Interactions
Drug Development and Regulation
Clinical Trials
Local Regulations
CASES

FIND THE RIGHT


POSITION
A 35-year old male patient a 29 year-old female patient
asked you about his upper desires to whiten her skin.
respiratory tract infection. He She inquired about IV
claims that he read in facebook
Glutathione. What
that herbal medications are
advantages does an IV
safer and more effective than
Glutathione have over that of
conventional medications. How
Oral Glutathione?
will you answer this statement.
STUDY OF SUBSTANCES
THAT INTERACT WITH
LIVING SYSTEMS
THROUGH CHEMICAL
PROCESSES.

PHARMACOLOGY
SCIENCE OF SUBSTANCES
USED TO PREVENT,
DIAGNOSE AND TREAT
DISEASE.
MEDICAL
PHARMACOLOGY
HISTORY OF PHARMACOLOGY

1500'S 17TH CENTURY 18TH AND 19TH PRESENT


Humorism Materia Medica CENTURY Controlled Clinical Trials
Experimental Physiology Evidence-Based
Excess or deficiency in Precursor of and Pharmacology Medicine
the four humours cause Pharmacology Pharmacogenomics
disease versus
Alternative Herbal
Medicine
GENERAL PRINCIPLES

CHEMICALS IN ALL SUPPLEMENTS


ALL SUBSTANCES CAN
BOTANICALS ARE NO SHOULD MEET THE SAME
UNDER CERTAIN
DIFFERENT FROM STANDARDS OF EFFICACY
CIRCUMSTANCES BE
MANUFACTURED EXCEPT AND SAFETY AS
TOXIC
FOR THE MUCH GREATER CONVENTIONAL DRUGS
IMPURITIES IN THE
BOTANICALS
DRUG SIZE
PHYSICAL NATURE
MW 100 - 1000 OF DRUGS
Lower limit = Higher Selective
Bonding
Upper limit = movement within the
body

DRUG RECEPTOR BONDS

Covalent Bonds DRUG SHAPE


Electrostatic Bonds
Hydrophobic Bonds
*Weaker bonds are more receptor
selective
Aspirin (Acetylsalicylic Acid)
irreversible inhibitor of Cyclooxygenase 1
PHARMACODYNAMICS PHARMACOKINETICS
ACTIONS OF THE BODY ON THE
ACTIONS OF THE DRUG ON THE
DRUG
BODY
PHARMACOKINETICS

ABSORPTION DISTRIBUTION METABOLISM ELIMINATION


PERMEATION
New Drugs

Discovery Development Screening


NO-EFFECT DOSE

Preclinical Maximum dose at which a


specified toxic effect is not seen.

Safety and
Toxicity Testing MINIMUM LETHAL DOSE
Smallest dose that is observed to
kill any experimental animal

MEDIAN LETHAL DOSE 


The dose that kills approximately
50% of the test animals
GENERICS ACT OF
LOCAL DRUG
1998 (RA 6675) REGULATIONS

FDA ACT OF 2009


(RA 9711) COMPREHENSIVE
DANGEROUS DRUGS
ACT OF 2002 (RA
9165)

You might also like